September 17, 2019 (Source) – Izotropic Corporation (Symbol IZO on the CSE in Canada) (CNSX:IZO.CN) (OTC:IZOZF) announces new listings on the OTC market in the USA under the stock symbol “IZOZF”, and on the FRA market in Germany under the stock symbol “1R3”.-
The Company has added these two listings to broaden its exposure to investors and generate awareness for its technology and mandate.
On behalf of the Board of Directors
R.L Thast
About Izotropic Corp.
The company is engaged in the development and commercialization of next-generation, 3-D breast CT imaging technology for early diagnosis of breast cancer, that improves patient comfort, provides a true 360-degree-view acquisition and delivers high diagnostic accuracy.
The company has also established a wholly owned U.S subsidiary called Izotropic Imaging Corp in 2016 to advance the company’s breast imaging development.
